Published on 2 Nov 2023 on Insider Monkey via Yahoo Finance
Should You Consider Adding DXC Technology Company (DXC) to Your Portfolio?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. During the quarter the strategy returned -6.0% net of fees compared to the S&P 500’s -3.3% return. As the quarter demonstrated, the markets are uncertain. In addition, you can check the top 5 holdings of the fund to know its best picks in 2023.
Patient Capital Management highlighted stocks like DXC Technology Company (NYSE:DXC) in the Q3 2023 investor letter. Headquartered in Ashburn, Virginia, DXC Technology Company (NYSE:DXC) is an information technology company that operates through Global Business Services (GBS) and Global Infrastructure Services (GIS) segments. On November 1, 2023, DXC Technology Company (NYSE:DXC) stock closed at $20.29 per share. One-month return of DXC Technology Company (NYSE:DXC) was -4.47%, and its shares lost 21.08% of their value over the last 52 weeks. DXC Technology Company (NYSE:DXC) has a market capitalization of $4.163 billion.
Patient Capital Management made the following comment about DXC Technology Company (NYSE:DXC) in its Q3 2023 investor letter: